- Home
- FATE vs GGZ Comparison
FATE vs GGZ Comparison
Compare FATE & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- GGZ
- Stock Information
- Founded
- FATE 2007
- GGZ 2013
- Country
- FATE United States
- GGZ United States
- Employees
- FATE N/A
- GGZ N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- GGZ Investment Managers
- Sector
- FATE Health Care
- GGZ Finance
- Exchange
- FATE Nasdaq
- GGZ Nasdaq
- Market Cap
- FATE 116.5M
- GGZ 109.0M
- IPO Year
- FATE 2013
- GGZ N/A
- Fundamental
- Price
- FATE $0.96
- GGZ $14.42
- Analyst Decision
- FATE Hold
- GGZ
- Analyst Count
- FATE 6
- GGZ 0
- Target Price
- FATE $3.30
- GGZ N/A
- AVG Volume (30 Days)
- FATE 1.4M
- GGZ 12.8K
- Earning Date
- FATE 11-11-2025
- GGZ 01-01-0001
- Dividend Yield
- FATE N/A
- GGZ 5.39%
- EPS Growth
- FATE N/A
- GGZ N/A
- EPS
- FATE N/A
- GGZ 1.75
- Revenue
- FATE $8,470,000.00
- GGZ N/A
- Revenue This Year
- FATE N/A
- GGZ N/A
- Revenue Next Year
- FATE N/A
- GGZ N/A
- P/E Ratio
- FATE N/A
- GGZ $6.79
- Revenue Growth
- FATE N/A
- GGZ N/A
- 52 Week Low
- FATE $0.66
- GGZ $9.43
- 52 Week High
- FATE $4.20
- GGZ $12.50
- Technical
- Relative Strength Index (RSI)
- FATE 40.81
- GGZ 64.22
- Support Level
- FATE $0.93
- GGZ $14.27
- Resistance Level
- FATE $1.08
- GGZ $14.65
- Average True Range (ATR)
- FATE 0.07
- GGZ 0.23
- MACD
- FATE -0.01
- GGZ -0.01
- Stochastic Oscillator
- FATE 13.79
- GGZ 48.08
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.